Top Biopharma Movers of the Past Week
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. However things look like they could be different in 2017.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 175
Is There More Than Meets the Eye on Celgene’s President, COO Retirement?
Celgene shares were trading lower on Friday due to a key management retirement. The problem is that this retirement is just sort out of the blue and was after a rather short tenure.
Is This the Turnaround Cempra Has Been Looking For?
Shares of Cempra saw an incredible gain on Friday after the company announced the results from its late-stage trial for the treatment of patients with acute bacterial skin and skin structure infections.
Large Cap Biotech Stocks to Buy May Be the Cheapest in Years
One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is the large cap biotechs.
With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra Oncology
After a fresh capital raise of about $26 million, at least one analyst is calling for Sierra Oncology stock to more than double.
Tuesday’s Top Biopharma Movers
A few biopharma companies have made massive runs on Tuesday morning.
What Are the Odds That Your Medical Information Has Been Stolen?
A recent survey showed that one in four U.S. consumers have had their personal medical information stolen from technology systems, and half of those who experienced a breach were victims of medical identity theft.
Why This FDA Approval for Valeant Is Not as Good as First Thought
Valeant Pharmaceuticals received a key FDA approval early on Thursday, but it seems to be a mixed blessing.
How Alexion’s Pipeline Is Driving Earnings
Alexion Pharmaceuticals released a mixed most recent earnings report before the markets opened on Thursday.
How Gene Editing Just Got Rocked by Major Patent Ruling
The possibilities around gene editing are almost endless. Some of the goals and hopes around gene editing sound like they were pulled right out of a science fiction or futuristic film. Imagine if you…
Has the IRS Driven the First Nail Into Obamacare’s Coffin?
The IRS will not require taxpayers to prove they had medical insurance last year, threatening the very existence of the Affordable Care Act, aka Obamacare.
Merck Delivers Even More Disappointing News in Alzheimer’s Study
Merck saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial for the treatment of Alzheimer’s disease.
Why Evoke Pharma Shares Are Exploding
Evoke Pharma saw its shares jump on Wednesday after the company issued an update that it received from the FDA.
What Analysts Are Saying About Teva Pharmaceutical After Earnings
After Teva Pharmaceutical International reported fourth-quarter and full-year 2016 on Monday, only a few analysts weighed in initially, but the consensus is slowly growing more negative.
Can Sage Therapeutics Press Even Further With Its Depression Trial?
Shares of Sage Therapeutics saw a handy gain on Monday after the company announced a successful mid-stage trial for the treatment of major depressive disorder.